Evidence map›Paper›PMID 28004038›Full record

ArticlePathogens & immunity

Increasing Rates of Fluoroquinolone Resistance in

Christopher G Hauck, Pearlie P Chong, Melissa B Miller, Katarzyna Jamieson, Jason P Fine, Matthew C Foster, Thomas C Shea, David van Duin

Abstract read
In one paragraph

Article in Pathogens & immunity. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Global impact of antibacterial resistance in patients with hematologic malignancies and hematopoietic cell transplant recipients.Transplant infectious disease : an official journal of the Transplantation Society · 2023
    Review
  6. Article
  7. Review
  8. Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2019
    Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Christopher G HauckDivision of Infectious Diseases, University of North Carolina, Chapel Hill, NC.
Pearlie P ChongDivision of Infectious Diseases, University of North Carolina, Chapel Hill, NC.
Melissa B MillerDepartment of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC.
Katarzyna JamiesonDivision of Hematology/Oncology, University of North Carolina, Chapel Hill, NC.
Jason P FineBiostatistics Department, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC.
Matthew C FosterDivision of Hematology/Oncology, University of North Carolina, Chapel Hill, NC.
Thomas C SheaDivision of Hematology/Oncology, University of North Carolina, Chapel Hill, NC.
David van DuinDivision of Infectious Diseases, University of North Carolina, Chapel Hill, NC.

Funding

Institutional Career Development CoreKL2TR001862 · NCATS · YALE UNIVERSITY · PI CANTLEY, LLOYD G, EDELMAN, E. JENNIFER · 2016 to 2025
$12.2M
TRAINING IN THE PATHOGENESIS OF INFECTIOUS DISEASEST32AI007517 · NIAID · YALE UNIVERSITY · PI Jaimie Meyer, Albert C Shaw · 1997 to 2026
$6.1M
TRAUMA RESEARCH FELLOWSHIPT32GM008450 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Bruce A Cairns, Anthony G Charles · 1992 to 2026
$3.8M
NCATS NIH HHS KL2 TR001862NIAID NIH HHS T32 AI007517NIGMS NIH HHS T32 GM008450
6 · The paper itself

Abstract

Fluoroquinolone (FQ) antibiotics have been shown to reduce mortality and the number of febrile episodes when used as prophylaxis during neutropenia. Prior studies suggest that prophylaxis may result in increasing rates of FQ resistance. Fluoroquinolone non-susceptibility trends in

Indexed as

Escherichia coliFluoroquinolone resistancehematologic malignancystem cell transplant

Identifiers

PMID28004038
PMCPMC5167534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.